Management Credibility Analysis
Upcoming Catalysts
Verified event feedCompany profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 1510 COTNER AVE, LOS ANGELES, CA
- Founded
- Not disclosed
📈 Company Timeline
RadNet, Inc. reported Another company event
RadNet, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.
Large-holder ownership filing
A holder reported or amended a beneficial ownership position of more than 5% in RadNet, Inc..
RadNet, Inc. filed Form 10-Q
RadNet, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
RadNet, Inc. reported Operating or financial results
RadNet, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
RadNet, Inc. reported A material agreement
RadNet, Inc. filed an 8-K covering a material agreement, a material financing obligation, Regulation FD disclosure, supporting financial statements or exhibits.
Capital Structure & Financial Position
Financial strength and liquidity analysisSource: SEC EDGAR company facts (opens in a new tab) Balance sheet dated
Peer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |
📋 Corporate Actions
Recent and upcoming corporate eventsFinancials
Financial statements and key metrics analysis| Quarter | Revenue (USD) | Operating income | Net income | Diluted EPS (USD) | Filed |
|---|---|---|---|---|---|
| Q2 2026 | $622.72M | $39.47M | $7.53M | $0.10 | 10-Q · 10 Aug 2026 |
| Q1 2026 | $575.63M | −$23.90M | −$33.47M | −$0.43 | 10-Q · 11 May 2026 |
| Q4 2025 | $547.71M | $27.83M | −$595,000 | Unavailable | 10-K · 2 Mar 2026 |
| Q3 2025 | $522.87M | $27.39M | $5.42M | $0.07 | 10-Q · 10 Nov 2025 |
| Q2 2025 | $498.23M | $30.88M | $14.45M | $0.19 | 10-Q · 11 Aug 2025 |
| Q1 2025 | $471.40M | −$24.10M | −$37.93M | −$0.51 | 10-Q · 12 May 2025 |
Analyst Consensus
Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 79.00–96.00 Ratings are third-party opinions, not advice.
💰 Upcoming Dividends
Next dividend paymentsGuidance Evolution
💼 Director Transactions
Recent insider activityTop Shareholders
Source: Nasdaq institutional holdings (opens in a new tab) Observed · 49 minutes ago